Timing of Heart Failure Medication Initiation After NSTEMI
Beta blockers should be started within the first 24 hours after NSTEMI in hemodynamically stable patients, and ACE inhibitors should be initiated as soon as safely possible—typically within the first 24 hours—particularly in patients with heart failure, reduced ejection fraction (LVEF ≤40%), hypertension, or diabetes. 1, 2, 3
Beta Blockers: Start Within 24 Hours
Oral beta blockers are indicated within the first 24 hours for all NSTEMI patients who do not have contraindications 2, 3:
Contraindications to immediate beta blocker initiation:
- Signs of heart failure (pulmonary congestion or low-output state)
- Increased risk for cardiogenic shock
- PR interval >0.24 seconds
- Second- or third-degree heart block without pacemaker
- Active asthma or reactive airway disease
- Severe bradycardia
Special considerations:
- For patients with moderate or severe LV dysfunction who remain stable: Beta blockers should still be initiated but with gradual titration 1
- For patients with initial contraindications: Reassess eligibility after 24 hours and initiate if contraindications have resolved 2
- Continue indefinitely after discharge for secondary prevention 1
ACE Inhibitors/ARBs: Start Within 24 Hours
ACE inhibitors should be given within the first 24 hours to high-risk NSTEMI patients 3:
Class I indications (must initiate):
- Heart failure present
- LVEF ≤40%
- Hypertension
- Diabetes mellitus
Initiation approach:
- Start with low-dose short-acting ACE inhibitor (e.g., captopril 1-6.25 mg) and titrate up 4
- Ensure systolic BP ≥100 mm Hg (or not >30 mm Hg below baseline) 4, 5
- Avoid IV ACE inhibitors in first 24 hours due to hypotension risk 5
ARB alternative:
- Use ARB if ACE inhibitor intolerant (cough or angioedema)
- Same indications and timing as ACE inhibitors 1, 3
Aldosterone Antagonists: Start Before Discharge
Mineralocorticoid receptor antagonists (eplerenone or spironolactone) should be prescribed before discharge for patients meeting all criteria 1, 6, 1:
Required criteria (all must be met):
- Already receiving therapeutic doses of ACE inhibitor (or ARB)
- LVEF ≤40%
- Either symptomatic heart failure OR diabetes mellitus
- Adequate renal function (creatinine clearance >30 mL/min)
- Potassium ≤5.0 mEq/L
Timing note:
The EPHESUS trial randomized patients at median 7.3 days post-MI, suggesting initiation can occur during hospitalization once hemodynamically stable 7
Critical Pitfalls to Avoid
Do not delay beta blockers in stable patients: The mortality benefit is established, and "within a few days" means start during hospitalization, not weeks later 1
Do not give IV beta blockers to high-risk patients: Those >70 years, heart rate >110 bpm, systolic BP <120 mm Hg, or late presentation are at increased shock risk 2
Do not withhold ACE inhibitors in preserved EF with high-risk features: Even without LV dysfunction, ACE inhibitors are reasonable (Class IIa) for all NSTEMI patients 1, 3
Reassess contraindications daily: Many initial contraindications (volume overload, hypotension) resolve with treatment, allowing medication initiation before discharge 2
Start medications in hospital, not as outpatient: Observational data show that in-hospital initiation significantly reduces 30-day mortality and readmission compared to post-discharge initiation 8
Algorithm Summary
Day 0-1 (First 24 hours):
- Oral beta blocker if no contraindications
- ACE inhibitor if high-risk features and BP adequate
- Reassess contraindications if initially present
Day 1-discharge:
- Initiate previously contraindicated medications if now safe
- Add aldosterone antagonist if LVEF ≤40% with HF/DM
- Ensure all medications continued at discharge
The key principle is early initiation during hospitalization with gradual titration, not delayed outpatient initiation. 1, 2, 3